Calcium Ascorbate PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
5743-27-1
Molecular formula
C12H14CaO12
Molecular weight
390.31 g/mol
Drug class
Vitamin C (ascorbic acid)water-soluble vitamin and reducing agent
Mechanism of action
Acts as an electron donor and cofactor for several dioxygenases, including prolyl and lysyl hydroxylases required for collagen synthesis, and enzymes involved in carnitine and catecholamine biosynthesis. It also functions as an antioxidant and supports normal immune function.
Indications / reported uses
Prevention and treatment of vitamin C deficiency and scurvy
Supplementation when dietary intake or absorption is inadequate; use for other conditions should not be inferred from nutritional or biochemical effects alone
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Calcium Ascorbate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Calcium Ascorbate Permitted Daily Exposure (PDE) report (the Calcium Ascorbate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Calcium Ascorbate Occupational Exposure Limit (OEL) report (the Calcium Ascorbate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.